d be counseled to take a dose of INBRIJA when the return of their Parkinson’ssymptoms (OFF periods) first occur [see Dosage and Administration (2.2)].
Instruct patients to read the Instructions for Use before using INBRIJA. Remind patients thatINBRIJA capsules should only be administered via the INBRIJA inhaler and the INBRIJAinhaler should not be used for administering other medications. Remind patients that thecontents of INBRIJA capsules are for oral inhalation only and must not be swallowed.
Instruct patients to keep INBRIJA capsules in their sealed blister packaging and to remove eachINBRIJA capsule immediately before using [see Dosage and Administration (2.1)].
Remind patients they need to orally inhale the contents of two capsules to take a full dose. Theyshould not take more than 5 doses of INBRIJA in one day. Instruct patients they should not takemore than one dose (2 capsules) per OFF period [see Dosage and Administration (2.2)].
Lung disease
Ask patients to report whether they develop asthma, COPD, or other chronic lung diseases, since
INBRIJA is not recommended in patients with these conditions [see Warnings and Precautions(5.6)].
Cough |
